Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Supplement: Applications of Novel CRISPR Tools
Experts in the Field Speak to the Ways CRISPR Is Used
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Literature Review: Defending against Virus, with a Little Help from Microbiome
A Specific Human-Associated Gut Microbe Produced DAT and Rescued Antibiotic-Treated Influenza-Infected Mice
For full access to this article login to GEN Select now.
Supplement: Viral Safety – Mitigate Your Risk
Experts from MilliporeSigma Highlight Different Aspects of Viral Safety
- Viral safety is a constant concern for all biopharmaceuticals as a contamination can cause significant regulatory concern and business disruption. A multilayered approach to virus safety across the full production landscape involves treating raw materials to prevent virus from entering the upstream process, testing intermediates to detect virus, and implementing purification and filtration ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.